Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F9G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,043
Award facts
- Contract value 100% obligated
- $17,043.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,043.36 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 26, 2026. The award was made on January 23, 2026, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat autoimmune and inflammatory conditions, demonstrating the Defense Logistics Agency's continued procurement of specialty pharmaceutical products to support military healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031. This comprehensive IDC enables the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support military treatment facilities and veterans' healthcare programs globally. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, competes on a full and open basis for federal contracts and has demonstrated its capability to efficiently fulfill government procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5F9G?
SPE2DR26F5F9G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F5F9G worth?
The government has obligated $17,043 on SPE2DR26F5F9G.
Is contract SPE2DR26F5F9G an order under another contract?
Yes. SPE2DR26F5F9G is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F9G competed?
The extent of competition for SPE2DR26F5F9G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award